By increasing IL-1β release through NLRP3 inflammasome accumulation and by macrophage self-recruitment through the CCL20 signaling pathway, the findings demonstrated that inhibiting tumor macrophage autophagy enhanced the advancement of HCC. The gene discussed is IL1B; the disease is hepatocellular carcinoma.